Bloomberg News

GlaxoSmithKline, ICAP May Move: U.K., Irish Equity Preview

July 08, 2011

July 7 (Bloomberg) -- The following is a list of companies that may have unusual share-price changes in U.K. and Irish markets. Stock symbols are in parentheses and prices are from the last market close.

The FTSE 100 Index rose 51.63 points, or 0.9 percent, to 6,054.55. The FTSE All-Share Index gained 0.8 percent to 3,154.10, while Ireland’s ISEQ Index advanced 0.3 percent to 2,968.17.

GlaxoSmithKline Plc (GSK LN): The U.K.’s biggest drugmaker said proposals to cut costs and transfer part of its Panadol production from Ireland to Spain will result in a loss of 130 jobs at its south-east Ireland plant. The stock gained 0.5 percent to 1,366.5 pence.

ICAP Plc (IAP LN): Principal Global Investors LLC agreed to pay $66 million for Origin Asset Management LLP, a money manager backed by ICAP Plc founder Michael Spencer. The stock advanced 2.1 percent to 490.6 pence.

--Editor: Jeff Sutherland

To contact the reporter on this story: Blanche Gatt in London at

To contact the editor responsible for this story: Colin Keatinge at

Best LBO Ever
blog comments powered by Disqus